Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 9/20 | 0.43 |
| ▸ | CTSL | P07711 | 5/20 | 0.40 |
| ▸ | CTSB | P07858 | 5/20 | 0.40 |
| ▸ | CTSH | P09668 | 3/20 | 0.40 |
| ▸ | LTA4H | P09960 | 1/20 | 0.40 |
| ▸ | GRN | P28799 | 1/20 | 0.40 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.40 |
| ▸ | CTSS | P25774 | 2/20 | 0.40 |
| ▸ | CPB2 | Q96IY4 | 4/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13957700 | 0.86 | GRN (0.49) | CTSKCTSLCTSBCTSHLTA4H | |
| SCHEMBL13672872 | 0.84 | GRN (0.41) | CTSKCTSLCTSBCTSHLTA4H | |
| SCHEMBL13038259 | 0.84 | GRN (0.41) | CTSKCTSLCTSBCTSHLTA4H | |
| SCHEMBL22133208 | 0.82 | CTSK (0.45) | CTSKCTSLCTSBCTSHLTA4H | |
| SCHEMBL16327608 | 0.82 | CTSK (0.45) | CTSKCTSLCTSBCTSHLTA4H | |
| SCHEMBL7207942 | 0.81 | REN (0.44) | CTSKCTSLCTSBLTA4HGRN | |
| SCHEMBL18435239 | 0.81 | CTSK (0.44) | CTSKCTSLCTSBCTSHCPB2 | |
| SCHEMBL13707910 | 0.81 | CTSK (0.44) | CTSKCTSLCTSBCTSHCPB2 | |
| SCHEMBL16171793 | 0.81 | CTSK (0.44) | CTSKCTSLCTSBCTSHLTA4H | |
| SCHEMBL13337029 | 0.81 | CTSK (0.44) | CTSKCTSLCTSBCTSHLTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007117560-A2 | PIPERIDINE AND MORPHOLINE RENIN INHIBITORS | VITAE PHARMACEUTICALS, INC. (US) | 2007-10-18 | — | — | WO | disclosed |